Literature DB >> 1356925

Forecasts of the costs of medical care for persons with HIV: 1992-1995.

F J Hellinger1.   

Abstract

This study concludes that the cumulative (national) cost of treating all persons with the human immunodeficiency virus (HIV) rose considerably over the past year and will continue to rise over the next several years. It is forecast that the cumulative cost of treating all persons with HIV will increase 48% from 1992 to 1995 (from $10.3 billion to $15.2 billion). It is estimated that the average yearly cost of treating a person with AIDS is $38,300 and of treating an infected person without AIDS is $10,000. The lifetime cost of treating a PWA is calculated to be $102,000. This is the first study to use, along with other data, data from the AIDS Cost and Service Utilization Survey to estimate the cost of treating persons with the HIV. The study also projects the number of AIDS cases to be 66,300 in 1992, 76,200 in 1993, 86,800 in 1994, and 97,800 in 1995.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356925

Source DB:  PubMed          Journal:  Inquiry        ISSN: 0046-9580            Impact factor:   1.730


  19 in total

1.  Understanding HIV-related risk among persons with a severe and persistent mental illness: insights from qualitative inquiry.

Authors:  C M Gordon; M P Carey; K B Carey; S A Maisto; L S Weinhardt
Journal:  J Nerv Ment Dis       Date:  1999-04       Impact factor: 2.254

2.  The impact of New York City's 1975 fiscal crisis on the tuberculosis, HIV, and homicide syndemic.

Authors:  Nicholas Freudenberg; Marianne Fahs; Sandro Galea; Andrew Greenberg
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

3.  Pharmacoeconomics of Pneumocystis carinii pneumonia in HIV-infected and HIV-noninfected patients.

Authors:  D P Nicolau; J W Ross; R Quintiliani; C H Nightingale
Journal:  Pharmacoeconomics       Date:  1996-07       Impact factor: 4.981

Review 4.  An overview of the effectiveness and efficiency of HIV prevention programs.

Authors:  D R Holtgrave; N L Qualls; J W Curran; R O Valdiserri; M E Guinan; W C Parra
Journal:  Public Health Rep       Date:  1995 Mar-Apr       Impact factor: 2.792

5.  The cost of a preventable disease: estimated U.S. national medical expenditures for congenital syphilis, 1990.

Authors:  G de Lissovoy; J Zenilman; K E Nelson; F Ahmed; D D Celentano
Journal:  Public Health Rep       Date:  1995 Jul-Aug       Impact factor: 2.792

6.  Measuring adolescent sexual behaviors and related health outcomes.

Authors:  L Morris; C W Warren; S O Aral
Journal:  Public Health Rep       Date:  1993       Impact factor: 2.792

Review 7.  Cost effectiveness of prophylaxis for opportunistic infections in AIDS. An overview and methodological discussion.

Authors:  K A Freedberg; A D Paltiel
Journal:  Pharmacoeconomics       Date:  1998-08       Impact factor: 4.981

Review 8.  Defining and measuring the costs of the HIV epidemic to business firms.

Authors:  P G Farnham
Journal:  Public Health Rep       Date:  1994 May-Jun       Impact factor: 2.792

9.  The use of health services by women with HIV infection.

Authors:  F J Hellinger
Journal:  Health Serv Res       Date:  1993-12       Impact factor: 3.402

10.  States' responses to Title II of the Ryan White CARE Act.

Authors:  M M McKinney; M K Wieland; G S Bowen; E P Goosby; K M Marconi
Journal:  Public Health Rep       Date:  1993 Jan-Feb       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.